Wenhui Wu

1.1k total citations
17 papers, 189 citations indexed

About

Wenhui Wu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Wenhui Wu has authored 17 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Wenhui Wu's work include Genetic factors in colorectal cancer (4 papers), Bacteriophages and microbial interactions (2 papers) and Mycobacterium research and diagnosis (2 papers). Wenhui Wu is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Bacteriophages and microbial interactions (2 papers) and Mycobacterium research and diagnosis (2 papers). Wenhui Wu collaborates with scholars based in China, United States and Australia. Wenhui Wu's co-authors include Scott Kopetz, Yao Yu, Michael J. Overman, Kanwal Raghav, Kerstin Trunzer, Kimberly C. Banks, Funda Meric‐Bernstam, Jennifer S. Davis, Kenna Shaw and Christopher A. Bristow and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Analytical Chemistry.

In The Last Decade

Wenhui Wu

14 papers receiving 187 citations

Peers

Wenhui Wu

ONCOL

PRM

PFM

Krisida Cerma Italy

Paul Westwood United Kingdom

Simona Bevilacqua Italy

Brian DiCarlo United States

Enrico Caliman Italy

Paul Tibbitts Ireland

Marina Shcherba United States

Rille Pihlak United Kingdom

Светлана Проценко Russia

Mirjam de With Netherlands

Krisida Cerma Italy

Wenhui Wu

137 ×1.3

ONCOL

74 ×0.8

64 ×1.3

PRM

47 ×1.1

57 ×1.5

PFM

Citations per year, relative to Wenhui Wu Wenhui Wu (= 1×) peers Krisida Cerma

Countries citing papers authored by Wenhui Wu

Since Specialization

Citations

This map shows the geographic impact of Wenhui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhui Wu more than expected).

Fields of papers citing papers by Wenhui Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhui Wu. The network helps show where Wenhui Wu may publish in the future.

Co-authorship network of co-authors of Wenhui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhui Wu. A scholar is included among the top collaborators of Wenhui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhui Wu. Wenhui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Shi, Jiahui, Zhiyuan Cheng, Wenhui Wu, et al.. (2025). Shotgun and targeted proteomics of Mycolicibacterium smegmatis highlight the role of arginine phosphorylation in the functional adaptation to its environment. Journal of Proteomics. 314. 105388–105388.

Sun, Yi, et al.. (2025). Sensitive and Deep Coverage Phosphoproteome Detection Method Reveals Spleen as a More Sensitive Organ than Liver in Early Detection of Liver Fibrosis-Related Signaling Protein Dysregulation. Analytical Chemistry. 97(4). 2283–2292.

Lv, Haitao, Meng Yuan, Jiao Wang, et al.. (2024). Genome-wide association analysis of cystatin c and creatinine kidney function in Chinese women. BMC Medical Genomics. 17(1). 272–272. 1 indexed citations

Düzağaç, Fahriye, Nan Deng, Laura Reyes-Uribe, et al.. (2024). Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology. 166(5). 787–801.e11. 17 indexed citations

Xia, Tingting, Weijia Xie, Na Wu, et al.. (2023). Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615. Journal of Cancer Research and Clinical Oncology. 149(20). 17781–17793. 1 indexed citations

Hu, Jian, et al.. (2023). Comparative proteomic analysis of vancomycin-sensitive and vancomycin-intermediate resistant Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases. 43(1). 139–153. 3 indexed citations

Shi, Jiahui, Yanchang Li, Zhenpeng Zhang, et al.. (2022). Mirror proteases of Ac-Trypsin and Ac-LysargiNase precisely improve novel event identifications in Mycolicibacterium smegmatis MC2 155 by proteogenomic analysis. Frontiers in Microbiology. 13. 1015140–1015140. 2 indexed citations

Borràs, Ester, Wenhui Wu, Kyle Chang, et al.. (2021). Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prevention Research. 14(9). 851–862. 10 indexed citations

Li, Junqing, et al.. (2021). Prognostic Value and Biological Functions of RNA Binding Proteins in Stomach Adenocarcinoma. OncoTargets and Therapy. Volume 14. 1689–1705. 16 indexed citations

10.

Chen, Jingyao, Jianfeng Li, Chumei Huang, et al.. (2020). A case of Castleman disease and literature review. 3. 79–79.

11.

Chen, Jingyao, Yubing Liu, Hong Yu, et al.. (2020). Advances in the application of prophylactic ostomy in radical resection of rectal cancer. 3. 60–60. 1 indexed citations

12.

Adam, Liana, F. Anthony San Lucas, Richard Fowler, et al.. (2018). DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clinical Cancer Research. 25(2). 641–651. 19 indexed citations

13.

Loree, Jonathan M., Ann M. Bailey, Amber M. Johnson, et al.. (2018). Molecular Landscape ofERBB2/ERBB3Mutated Colorectal Cancer. JNCI Journal of the National Cancer Institute. 110(12). 1409–1417. 48 indexed citations

14.

Gregg, Justin R., David S. López, Chad A. Reichard, et al.. (2018). Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active Surveillance. The Journal of Urology. 201(2). 308–314. 12 indexed citations

15.

Aparicio, Ana M., Lianchun Xiao, Elsa Li Ning Tapia, et al.. (2017). The aggressive variant prostate carcinoma (AVPC) molecular signature (-MS) and platinum-sensitivity in castration resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 35(15_suppl). 5013–5013. 16 indexed citations

16.

McArthur, Grant A., Antoni Ribas, Paul B. Chapman, et al.. (2011). Molecular analyses from a phase I trial of vemurafenib to study mechanism of action (MOA) and resistance in repeated biopsies from BRAF mutation–positive metastatic melanoma patients (pts).. Journal of Clinical Oncology. 29(15_suppl). 8502–8502. 28 indexed citations

17.

Lacouture, Mario E., Paul B. Chapman, Antoni Ribas, et al.. (2011). Presence of frequent underlying RAS mutations in cutaneous squamous cell carcinomas and keratoacanthomas (cuSCC/KA) that develop in patients during vemurafenib therapy.. Journal of Clinical Oncology. 29(15_suppl). 8520–8520. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact